Cannatrek

A licenced grower and supplier of medicinal cannabis products

Trade Now

INDUSTRY

Medical Cannabis

STATUS

Trading

OPEN TO

Public

Investment Highlights

Company Overview

Products & Services

Additional Information

News

Trade Now

Ask Us a Question Or Express Interest

Investment Highlights

Growing industry: Cannatrek operates in the rapidly expanding cannabis market, providing investors with significant growth potential as the industry continues to expand globally.

Strong leadership: Cannatrek is led by a team of experienced professionals with a proven track record in the cannabis industry, ensuring investors that their investment is in capable hands.

Diversified portfolio: Cannatrek offers a diverse range of products and services, including medicinal cannabis production, research, and distribution, providing investors with exposure to multiple revenue streams within the industry.

Regulatory advantage: With a strong focus on compliance and regulatory standards, Cannatrek is well-positioned to capitalize on the increasing legalization of cannabis around the world, making it a promising investment opportunity for investors looking to capitalize on this trend.

Leading Australian cannabis company:

Cannatrek is one of the leading licensed medicinal cannabis producers in Australia, with a state-of-the-art cultivation facility in Victoria.

Innovation and research:

Cannatrek is committed to advancing the science and research of medicinal cannabis, collaborating with leading universities and research institutions to develop innovative products and treatment options.

Sustainable practices:

Cannatrek is dedicated to sustainable cultivation practices, utilizing cutting-edge technology to minimize environmental impact and ensure high-quality, eco-friendly products.

Patient-focused approach:

Cannatrek prioritizes patient care and education, providing personalized treatment plans and support services to improve the health and well-being of individuals using medicinal cannabis.

Company Overview

Cannatrek is a leading Australian medicinal cannabis company that is dedicated to providing high-quality, sustainable products for patients in need. With a state-of-the-art cultivation facility in Victoria, Cannatrek is at the forefront of Australia's rapidly expanding cannabis industry.

The company is committed to innovation and research, working closely with universities and research institutions to develop cutting-edge products and treatment options. Cannatrek places a strong emphasis on sustainability, utilizing advanced technology to minimize environmental impact and ensure the production of eco-friendly cannabis products.

At the core of Cannatrek's mission is a patient-focused approach, with a dedication to providing personalized treatment plans and support services to improve the health and well-being of individuals using medicinal cannabis. With a strong emphasis on compliance and regulatory standards, Cannatrek is well-positioned to capitalize on the increasing legalization of cannabis around the world, making it a promising investment opportunity in the growing cannabis market.

Products & Services

Cannatrek offers a range of products and services in the medicinal cannabis industry, including:

Medicinal Cannabis: Cannatrek produces a variety of medicinal cannabis products, including oils, capsules, tinctures, and dried flowers, tailored to meet the specific needs of patients.

Research and Development: Cannatrek is actively involved in research and development initiatives to advance the science and understanding of medicinal cannabis, with a focus on developing innovative products and treatment options.

Patient Care and Support: Cannatrek provides personalized treatment plans and support services to patients using medicinal cannabis, including education, consultation, and ongoing care to ensure the best possible outcomes.

Cultivation and Production: Cannatrek operates a state-of-the-art cultivation facility in Victoria, utilizing sustainable practices and cutting-edge technology to produce high-quality, eco-friendly cannabis products for patients in need.

Previous Funding

Cannatrek raised A$2.5M in December 2020 at A$0.35c per share, since then they have partnered with Chemist Warehouse and recently signed an MOU with Japan in late 2023. They are expected to IPO next year (2025)